share_log
Reuters ·  Mar 18 12:06
Hoth Therapeutics Announces Positive Preclinical Results for Ht-Kit in Aggressive Cancer Gastrointestinal Stromal Tumors (Gist). Ht-Kit Triggered Significant Tumor Cell Death as Early as 24 Hours Post-Treatment
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 372

Recommended

Write a comment